在结核病治疗完成后对结核病后肺病进行查:症状是否足够?
Jamilah Meghji1, Vester Gunsaru2, Beatrice Chinoko2
1National Heart & Lung Institute, Imperial College London, London, United Kingdom.
PLOS global public health
|January 29, 2024
概括
肺结核 (TB) 幸存者经常经历长期的肺部疾病. 结核病治疗完成后的症状查有效地预测了结核病后的肺病 (PTLD),并可以指导护理,而螺旋计和成像几乎没有额外的益处.
科学领域:
- 肺部医学 肺部医学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 肺结核 (TB) 幸存者面临着巨大的后结核肺病 (PTLD) 的负担.
- 需要有效的查策略来识别低资源环境中面临PTLD风险的个体.
- 目前用于PTLD的预测模型通常缺乏在现实世界程序设置中的验证.
研究的目的:
- 评估结核病治疗完成时测量的参数在预测后续发病率方面的表现.
- 在资源有限的环境中为PTLD查提供信息的程序方法.
- 确定肺结核幸存者的不良结果的关键预测因素.
主要方法:
- 来自马拉维城市布兰泰尔的队列数据的二次数据分析.
- 为五个发病结果开发回归模型 (逻辑,惩罚,弹性网).
- 包括人口,临床,症状,螺旋测量和胸部X射线变量作为预测因素.
- 使用ROC AUC评估模型性能,并确定正负预测值 (NPV).
主要成果:
- 结核病治疗完成后的呼吸道症状是患病率最强的预测因素.
- 喘息强烈预测螺旋测量下降,健康寻求,和持续的症状/功能限制.
- 活动限制预测了未来的症状/功能限制和财务影响.
- 螺旋测量和胸部X射线参数没有显著改善模型性能.
- 对于不良结果,ROC AUC值在0.65-0.77之间;活动限制具有高的NPV (78-98%).
结论:
- 预测后结核病发病率是具有挑战性的,但在治疗完成后的症状查是优先考虑后结核病护理的有希望的方法.
- 基于症状的查可以有效地识别患有PTLD风险的个人.
- 螺旋测量和胸部成像在这种情况下为预测PTLD提供了有限的附加值.
更多相关视频
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
18.8K
03:47A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
224
相关概念视频
Pulmonary Tuberculosis IV
143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143
Pulmonary Tuberculosis V
180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
Pulmonary Tuberculosis III
332
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
332
Pulmonary Tuberculosis II
239
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
239
Pulmonary Tuberculosis I
243
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
243
Pneumothorax-II
150
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
150
